San Francisco, CA, United States of America

Joshua Taygerly


 

Average Co-Inventor Count = 10.6

ph-index = 3

Forward Citations = 36(Granted Patents)


Location History:

  • San Francisco, CA (US) (2017 - 2022)
  • Thousand Oaks, CA (US) (2020 - 2022)

Company Filing History:


Years Active: 2017-2022

Loading Chart...
Loading Chart...
8 patents (USPTO):

Certainly! Here is an article about the inventor Joshua Taygerly:

Title: Unveiling the Innovations of Inventor Joshua Taygerly

Introduction: Joshua Taygerly, a prolific inventor based in San Francisco, CA, has made significant advancements in the field of pharmaceuticals with his groundbreaking patents. Holding a total of 8 patents, Joshua is known for his contributions towards developing compounds that inhibit the MCL-1 protein, offering new possibilities in the treatment of diseases like cancer.

Latest Patents:

In his latest patents, Joshua Taygerly has introduced compounds that inhibit the MCL-1 protein. These inhibitors, including compounds of Formula I, present innovative methods of preparation, pharmaceutical compositions, and usage in disease treatment, particularly in cancer therapeutics.

Career Highlights:

Joshua Taygerly is associated with Amgen Inc., a renowned biotechnology company. Within the organization, he has demonstrated a remarkable prowess in translating scientific discoveries into tangible solutions that have the potential to revolutionize the healthcare industry.

Collaborations:

Joshua Taygerly has collaborated with esteemed professionals such as Sean P Brown and Yunxiao Li. Together, they have synergized their expertise to drive forward pioneering research initiatives and bring about transformative innovations in the pharmaceutical domain.

Conclusion:

Inventor Joshua Taygerly's dedication to pushing the boundaries of scientific exploration and his relentless pursuit of advancements in the field of pharmaceuticals exemplify his commitment to improving the lives of individuals worldwide. Through his inventive spirit and collaborative efforts, Joshua continues to pave the way for novel therapeutic interventions that hold promise for the future of healthcare.

Should you need additional information or have any specific requests, feel free to let us know!

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…